Group One Trading, L.P. Esperion Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 183,651 shares of ESPR stock, worth $442,598. This represents 0.01% of its overall portfolio holdings.

Number of Shares
183,651
Previous 17,453 952.26%
Holding current value
$442,598
Previous $38,000 697.37%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.61 - $2.73 $267,578 - $453,720
166,198 Added 952.26%
183,651 $303,000
Q2 2024

Aug 14, 2024
SELL
$1.84 - $3.24 $190,083 - $334,711
-103,306 Reduced 85.55%
17,453 $38,000
Q1 2024

May 10, 2024
BUY
$2.02 - $3.02 $243,933 - $364,692
120,759 New
120,759 $323,000
Q3 2023

Nov 09, 2023
SELL
$0.96 - $1.79 $10,586 - $19,740
-11,028 Reduced 3.43%
310,778 $304,000
Q2 2023

Aug 09, 2023
SELL
$1.2 - $1.76 $30,124 - $44,183
-25,104 Reduced 7.24%
321,806 $447,000
Q1 2023

May 12, 2023
BUY
$1.46 - $7.3 $124,916 - $624,580
85,559 Added 32.74%
346,910 $551,000
Q4 2022

Feb 09, 2023
BUY
$5.09 - $8.5 $1.33 Million - $2.22 Million
261,351 New
261,351 $1.63 Million
Q4 2021

Feb 11, 2022
SELL
$4.81 - $11.92 $75,776 - $187,787
-15,754 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$11.34 - $21.37 $44,736 - $84,304
-3,945 Reduced 20.03%
15,754 $190,000
Q2 2021

Aug 10, 2021
BUY
$19.4 - $28.71 $156,305 - $231,316
8,057 Added 69.21%
19,699 $417,000
Q1 2021

May 12, 2021
BUY
$25.12 - $36.89 $292,447 - $429,473
11,642 New
11,642 $327,000
Q3 2019

Nov 12, 2019
SELL
$34.47 - $47.53 $416,328 - $574,067
-12,078 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$40.1 - $52.33 $39,217 - $51,178
978 Added 8.81%
12,078 $562,000
Q1 2019

May 13, 2019
BUY
$40.11 - $53.57 $313,259 - $418,381
7,810 Added 237.39%
11,100 $446,000
Q4 2018

Feb 06, 2019
SELL
$36.99 - $59.11 $217,982 - $348,335
-5,893 Reduced 64.17%
3,290 $151,000
Q3 2018

Nov 08, 2018
SELL
$40.74 - $51.41 $1.17 Million - $1.48 Million
-28,708 Reduced 75.76%
9,183 $407,000
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $653,880 - $1.38 Million
18,063 Added 91.1%
37,891 $1.49 Million
Q1 2018

May 11, 2018
BUY
$65.94 - $80.76 $988,242 - $1.21 Million
14,987 Added 309.58%
19,828 $1.43 Million
Q4 2017

Feb 09, 2018
BUY
$43.47 - $67.43 $210,438 - $326,428
4,841 New
4,841 $319,000
Q3 2017

Nov 15, 2017
SELL
$43.8 - $52.77 $473,477 - $570,443
-10,810 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
10,810
10,810 $500,000

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email